0.70 - 0.75
0.33 - 0.86
15.11M / 4.66M (Avg.)
35.00 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-30.24%
Negative revenue growth while 0335.HK stands at 139.00%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-24.76%
Negative gross profit growth while 0335.HK is at 138.80%. Joel Greenblatt would examine cost competitiveness or demand decline.
46.87%
EBIT growth below 50% of 0335.HK's 119.34%. Michael Burry would suspect deeper competitive or cost structure issues.
46.87%
Operating income growth at 50-75% of 0335.HK's 62.54%. Martin Whitman would doubt the firm’s ability to compete efficiently.
-112.51%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-112.61%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-114.85%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-1.05%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-14.84%
Reduced diluted shares while 0335.HK is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-146.12%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-96.66%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-33.83%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-41.53%
Negative 5Y CAGR while 0335.HK stands at 56.39%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-33.91%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-2026.74%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-330.94%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-107.08%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-102.98%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-105.81%
Negative 5Y net income/share CAGR while 0335.HK is 50.65%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-104.20%
Negative 3Y CAGR while 0335.HK is 24.67%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
631.56%
Equity/share CAGR of 631.56% while 0335.HK is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
14.54%
Below 50% of 0335.HK's 82.55%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
19.89%
3Y equity/share CAGR similar to 0335.HK's 20.54%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
-92.85%
Cut dividends over 10 years while 0335.HK stands at 169.76%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-19.58%
Negative 5Y dividend/share CAGR while 0335.HK stands at 11.11%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-39.20%
Negative near-term dividend growth while 0335.HK invests at 33.34%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-22.12%
Firm’s AR is declining while 0335.HK shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
23.92%
Inventory growth of 23.92% while 0335.HK is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
-8.19%
Negative asset growth while 0335.HK invests at 11.74%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.51%
Positive BV/share change while 0335.HK is negative. John Neff sees a clear edge over a competitor losing equity.
38.08%
Debt shrinking faster vs. 0335.HK's 10546.59%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
-67.10%
Our R&D shrinks while 0335.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-20.20%
We cut SG&A while 0335.HK invests at 48.87%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.